Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease

Zoe Boyer‐Díaz, Jordi Gracia‐Sancho, Anabel Fernández‐Iglesias et al.|Journal of Hepatology|2020

Cited by 163